Rising recession risk favors defensive dividend stocks, cash and Treasuries.
After years of playing defense, it's time to think offense.
Selling equities into rally as outlook for 'Rocky Landing' grows more likely.
Our international team sees opportunity in China, Asia.
Nearing level to leg back in but staying defensive as Fed attempts 'rocky landing.'
Fed should give investors no reason to stray from short-duration, value strategies.
Consumers powered the recovery and markets. Will they hold up?
A near-term bottom may be in sight.
It will (it always has). Growth investors need to be ready.
More rate hikes would favor cash, floating-rate securities and value stocks.
5 reasons growth investors can take heart in 2022.
Today's challenges play into this asset class' strengths.
Year-end S&P forecasts for 2022 and 2023 lowered to 4,800 and 5,100.
Scenarios vary but on a 12-month view, stocks should be higher from here.
Health-care innovation continues to accelerate.
Shortages shed light on role of microchips in unlocking information's value.
Megatrends and secular shifts continue to create long-term opportunities.
Robust spending and low delinquencies bode well for yields.
Companies with pricing power still offering potential.
Finding value in a frequently misunderstood sector.
Still room to run, with a tilt toward cyclical companies with pricing power.
Investors uncertain as country shifts from fighting poverty to fighting inequality.
3 sectors may help investors deal with market obstacles.